Skip to content

2020

Long-term outcome of Crohn’s disease patients with upper gastrointestinal stricture: a GETAID study

Articles,2020
T. Lambin, A. Amiot, J.M. Gornet, P. Seksik, D. Laharie, E. Louis, C. Giletta, J. Filippi, M. Fumery, G. Cadiot, G. Pineton de Chambrun, S. Nahon, M. Serrero, B. Coffin, L. Plastaras, S. Viennot,…
Lire la suite

IMPACT OF AN EDUCATION PROGRAM ON IBD PATIENT’S SKILLS: RESULTS OF A RANDOMIZED CONTROLLED MULTICENTER STUDY (ECIPE)

Articles,2020
J. Moreau, L. Marthey, C. Trang, M. Nachury, R. Altwegg, J.-C. Grimaud, S. Orempuller, J. Filippi, A. Aubourg, C. Baudry,P. Seksik, X. Roblin, S. Nahon, G. Savoye, B. Mesnard,C. Stefanescu, M. Simon, B. Coffin,…
Lire la suite

Surgery for Crohn’s disease during pregnancy: A nationwide survey

Articles,2020
Germain A, Chateau T, Beyer-Berjot L, Zerbib P, Lakkis Z, Amiot A, Buisson A, Laharie D, Lefevre JH, Nancey S, Stefanescu C, Bresler L, Peyrin-Biroulet L (United European Gastroenterol J. 2020 Jul;8(6):736-740 – PMID: 32326876)…
Lire la suite

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study

Articles,2020
Amiot A, Filippi J, Abitbol V, Cadiot G, Laharie D, Serrero M, Altwegg R, Bouhnik Y, Peyrin-Biroulet L, Gilletta C, Roblin X, Pineton de Chambrun G, Vuitton L, Bourrier A, Nancey S, Gornet JM,…
Lire la suite

Vedolizumab for perianal Crohn’s disease: a multicentre cohort study in 151 patients

Articles,2020
Chapuis-Biron C, Bourrier A, Nachury M, Nancey S, Bouhnik Y, Serrero M, Armengol-Debeir L, Buisson A, Tran-Minh ML, Zallot C, Fumery M, Bouguen G, Abitbol V, Viennot S, Chanteloup E, Rajca S, Dib N,…
Lire la suite

Maintenance of remission among patients with inflammatory bowel disease after vedolizumab discontinuation: a multicentre cohort study.

Articles,2020
Martin A, Nachury M, Peyrin-Biroulet L, Bouhnik Y, Nancey S, Bourrier A, Serrero M, Fumery M, Buisson A, Laharie D, Gilletta C, Filippi J, Allez M, Bouguen G, Roblin X, Altwegg R, Dib N,…
Lire la suite

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease

Articles,2020
Dulai PS, Amiot A, Peyrin-Biroulet L, Jairath V, Serrero M, Filippi J, Singh S, Pariente B, Loftus EV Jr, Roblin X, Kane S, Buisson A, Siegel CA, Bouhnik Y, Sandborn WJ, Lasch K, Rosario…
Lire la suite

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

Articles,2020
Pineton de Chambrun G, Amiot A, Bouguen G, Viennot S, Altwegg R, Louis E, Collins M, Fumery M, Poullenot F, Armengol L, Buisson A, Abitbol V, Laharie D, Seksik P, Nancey S, Blanc P,…
Lire la suite

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn’s Disease

Articles,2020
Bouguen G, Huguet A, Amiot A, Viennot S, Cholet F, Nachury M, Flamant M, Reimund JM, Desfourneaux V, Boureille A, Siproudhis L (Clin Gastroenterol Hepatol. 2020 Mar;18(3):628-636 – PMID: 31128337) https://pubmed.ncbi.nlm.nih.gov/31128337/
Lire la suite

Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease

Articles,2020
Dreesen E, Baert F, Laharie D, Bossuyt P, Bouhnik Y, Buisson A, Lambrecht G, Louis E, Oldenburg B, Pariente B, Pierik M, van der Woude CJ, D’Haens G, Vermeire S, Gils A (Clin Gastroenterol…
Lire la suite

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

Articles,2020
Lair-Mehiri L, Stefanescu C, Vaysse T, Laharie D, Roblin X, Rosa I, Treton X, Abitbol V, Amiot A, Bouguen G, Dib N, Fumery M, Pariente B, Carbonnel F, Peyrin-Biroulet L, Simon M, Viennot S,…
Lire la suite

La version de votre navigateur est obsolète et votre appareil est exposé à des risques de sécurité.

Pour profiter d'une expérience optimale sur ce site il est fortement recommandé de mettre à jour votre navigateur ou d'en installer un autre :